Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebrospinal-fluid-related biomarkers for drugs affecting amyloid burden

  • Email
  • Help

Document details

Download document Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebrospinal-fluid-related biomarkers for drugs affecting amyloid burden
Reference number EMA/CHMP/SAWP/102001/2011
Status adopted
First published 2011-05-16
Last updated 2011-05-16